Vasopressin

New to peptides? Start with what are peptides? and how do peptides work?

Overview

Vasopressin is one of the few entries in this encyclopedia that is primarily a description of your own physiology. It is a nine-amino-acid hormone made in the hypothalamus and released from the posterior pituitary, and it is the master regulator of how much water your body keeps. Its alternative name, antidiuretic hormone, describes what it does; its primary name describes its other job, pressing on blood vessels.

The hormone

Specialized cells in the hypothalamus continuously sense the concentration of your blood. When you become even slightly dehydrated, they trigger vasopressin release, the kidneys retain water, urine becomes concentrated, and thirst is stimulated. When you drink more than you need, vasopressin falls and dilute urine is produced. This runs constantly and unnoticed, and it is why the body defends its water content within a remarkably narrow range.

The medicine

Synthetic vasopressin is also an important hospital drug, but for its other property. In septic and other vasodilatory shock, blood vessels lose their tone and blood pressure falls despite adequate fluid. Vasopressin restores vascular tone through a receptor pathway entirely separate from the catecholamines like norepinephrine, which makes it a genuinely complementary agent rather than a substitute.

This dual identity is worth keeping straight. As a hormone, vasopressin is endogenous and universal. As a drug, it is an FDA-approved, intensive-care-only injectable — and notably, it was marketed for decades in the United States as an unapproved product before Vasostrict became the first formally approved version in 2014.

How it works

Three receptors, three jobs

• V1a receptors on vascular smooth muscle cause vasoconstriction, raising blood pressure. This is the effect exploited in shock.
• V2 receptors in the kidney's collecting ducts insert aquaporin-2 water channels, reabsorbing water and concentrating the urine. This is the antidiuretic effect.
• V1b receptors in the pituitary contribute to ACTH release, linking vasopressin to the stress-hormone axis.

Why this matters for the related drugs

Almost every clinically useful vasopressin analog is an attempt to isolate one of these actions. Desmopressin was engineered to keep V2 and drop V1a, giving water retention without vasoconstriction. Terlipressin leans toward V1 and toward the splanchnic circulation, giving vasoconstriction where it is wanted in liver disease. Understanding the receptor map makes the whole family intelligible at a glance.

Vasopressin in shock

In septic shock, circulating vasopressin levels are often inappropriately low — a relative deficiency — and the vasculature remains responsive to it even when it has become less responsive to catecholamines. Adding vasopressin therefore raises blood pressure and typically allows the norepinephrine dose to be reduced. Because it acts through V1a rather than adrenergic receptors, it does not add to the adrenergic burden on the heart in the same way.

Clinical uses & evidence

Vasodilatory and septic shock

Vasopressin is used as an adjunct to catecholamine vasopressors in septic shock. Randomized evidence has generally shown that adding it reduces catecholamine requirements, with the effect on mortality less clear-cut overall and possible benefit in specific subgroups. Major sepsis guidelines position it as a second-line agent added when norepinephrine alone is insufficient, rather than as a first-line replacement. It is also used in vasodilatory shock after cardiac surgery and in some cases of shock refractory to other agents.

Kidney effects

Some evidence suggests vasopressin use in shock is associated with reduced need for renal replacement therapy compared with catecholamines alone, which is a plausible consequence of preserving renal perfusion pressure without excessive adrenergic stimulation. This remains an area of active study rather than a settled conclusion.

Water-balance disorders

Because vasopressin deficiency causes central diabetes insipidus, vasopressin biology underlies that entire condition — but treatment uses desmopressin rather than vasopressin itself, precisely because the V2 selectivity avoids unwanted pressor effects. Conversely, inappropriate vasopressin excess causes the syndrome of inappropriate antidiuretic hormone secretion, a common cause of hyponatremia in hospitalized patients. In that direction, drugs that block V2 receptors are the treatment.

Cardiac arrest

Vasopressin has been studied in cardiac arrest, alone and combined with epinephrine and steroids. Evidence has been mixed, and current resuscitation guidelines do not recommend it as a routine substitute for epinephrine.

Forms & how it's given

As a medicine, vasopressin is given by continuous intravenous infusion in an intensive care unit or operating room, titrated by clinicians against blood-pressure targets with continuous hemodynamic monitoring. It is typically run at fixed low infusion rates rather than aggressively titrated like catecholamines, and weaning is done gradually.

There is no oral form, no outpatient use, and no self-administration. This is a critical-care drug administered by trained staff to patients who are, by definition, seriously ill.

No consumer dosing exists. We do not publish dosing information for any peptide, and in this case the question does not arise outside a hospital setting.

Safety & legal status

Ischemia is the principal concern

Vasopressin constricts blood vessels throughout the body, not selectively. At higher doses this can reduce blood flow to the heart, gut, skin, and extremities, producing myocardial ischemia, mesenteric ischemia, and peripheral or digital necrosis. These risks are the reason infusion rates are kept conservative and patients are monitored continuously.

Other effects

• Hyponatremia from excessive water retention through V2 activation.
• Reduced cardiac output in some patients, since raising afterload increases the work the heart must do.
• Arrhythmias and bradycardia.
• Local tissue injury if the infusion extravasates from the vein.

Legal status

The natural hormone is endogenous and needs no legal classification. The injectable medicine is FDA-approved and prescription-only, restricted in practice to hospital settings. There is no legitimate consumer market for vasopressin, and it should not be confused with the vasopressin-analog products that appear in wellness contexts — desmopressin, for water balance, is the analog with outpatient use, and it is likewise prescription-only.

Vasopressin and its analogs compared

Natural vasopressin does two unrelated jobs — it makes the kidneys retain water (V2) and constricts blood vessels (V1). Each analog was engineered to isolate one of them, which is why they end up in completely different parts of the hospital.

Frequently asked questions

References

Each source links to its original record — peer-reviewed studies, regulator pages, or reference texts, labelled by type. We summarize findings neutrally; a citation is a reference, not an endorsement, and not a claim that its authors reviewed this page.

1. Lajoye Q, Orieux A, Boyer A, et al. Vasopressin and its analogues in patients with septic shock: holy Grail or unfulfilled promise? Crit Care. 2025. Peer-reviewed study
2. Bauer SR, Lam SW. Arginine vasopressin for the treatment of septic shock in adults. Pharmacotherapy. 2010. Peer-reviewed study
3. Hoorn EJ, Zietse R. Diagnosis and Treatment of Hyponatremia: Compilation of the Guidelines. J Am Soc Nephrol. 2017. Peer-reviewed study
4. Ukor IF, Walley KR. Vasopressin in Vasodilatory Shock. Crit Care Clin. 2019. Peer-reviewed study